Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
The Oncologist
|
June 3, 2026
Assessing Contribution of Effect in Oncology Combination Therapies: Lessons Learned to Inform and Optimize Future Registrational Trial Designs
Hillary Andrews, Raja Agnihotram, Gideon Blumenthal, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 22, 2025
Surgical Outcomes With Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC
Tetsuya Mitsudomi, John V Heymach, Martin Reck, et al.
The New England Journal of Medicine
|
October 23, 2023
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer
John V Heymach, David Harpole, Tetsuya Mitsudomi, et al.
Cancer Cell
|
June 2, 2023
Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer
Scott Haston, Estela Gonzalez-Gualda, Samir Morsli, et al.
Nature Aging
|
February 3, 2026
Treatment resistance to platinum-based chemotherapy in lung and ovarian cancer is driven by a targetable TGFβ senescent secretome
Estela González-Gualda, Marika A V Reinius, David Macias, et al.
Ecancermedicalscience
|
October 21, 2020
The care of older cancer patients in the United Kingdom
Fabio Gomes, Anna Lewis, Rob Morris, et al.
Nature Genetics
|
July 31, 2025
Author Correction: The long-term effects of chemotherapy on normal blood cells
Emily Mitchell, My H Pham, Anna Clay, et al.
Nature Genetics
|
July 2, 2025
The long-term effects of chemotherapy on normal blood cells
Emily Mitchell, My H Pham, Anna Clay, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
The Oncologist
|
June 3, 2026
Assessing Contribution of Effect in Oncology Combination Therapies: Lessons Learned to Inform and Optimize Future Registrational Trial Designs
Hillary Andrews, Raja Agnihotram, Gideon Blumenthal, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 22, 2025
Surgical Outcomes With Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC
Tetsuya Mitsudomi, John V Heymach, Martin Reck, et al.
The New England Journal of Medicine
|
October 23, 2023
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer
John V Heymach, David Harpole, Tetsuya Mitsudomi, et al.
Cancer Cell
|
June 2, 2023
Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer
Scott Haston, Estela Gonzalez-Gualda, Samir Morsli, et al.
Nature Aging
|
February 3, 2026
Treatment resistance to platinum-based chemotherapy in lung and ovarian cancer is driven by a targetable TGFβ senescent secretome
Estela González-Gualda, Marika A V Reinius, David Macias, et al.
Ecancermedicalscience
|
October 21, 2020
The care of older cancer patients in the United Kingdom
Fabio Gomes, Anna Lewis, Rob Morris, et al.
Nature Genetics
|
July 31, 2025
Author Correction: The long-term effects of chemotherapy on normal blood cells
Emily Mitchell, My H Pham, Anna Clay, et al.
Nature Genetics
|
July 2, 2025
The long-term effects of chemotherapy on normal blood cells
Emily Mitchell, My H Pham, Anna Clay, et al.
Page
of 4